Centiva Capital, LP Horizon Therapeutics Public LTD CO Call Options Transaction History

Centiva Capital, LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $481,700 - $561,900	5,000 Added 1000.0%	5,500 $565,000
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $5.85 Million - $6.19 Million	-54,500 Reduced 99.09%	500 $54,000
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $3.4 Million - $6.2 Million	54,500 Added 10900.0%	55,000 $6.26 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $29,460 - $42,335	500 New	500 $31,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.